| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |